Ocumension Therapeutics (HKG:1477)
Hong Kong · Delayed Price · Currency is HKD 7.00
+0.10 (1.45%)
Feb 13, 2026, 4:08 PM HKT
Ocumension Therapeutics Market Cap
Ocumension Therapeutics has a market cap or net worth of 5.63 billion as of February 13, 2026. Its market cap has increased by 68.06% in one year.
Market Cap
5.63B
Enterprise Value
5.08B
Revenue
595.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.00
Market Cap Chart
Since July 10, 2020, Ocumension Therapeutics's market cap has decreased from 21.28B to 5.63B, a decrease of -73.57%. That is a compound annual growth rate of -21.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 5.71B | -5.41% |
| Dec 31, 2025 | 6.03B | 64.39% |
| Dec 31, 2024 | 3.67B | -20.44% |
| Dec 29, 2023 | 4.61B | -30.21% |
| Dec 30, 2022 | 6.61B | -43.35% |
| Dec 31, 2021 | 11.67B | -26.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CK Life Sciences Int'l., (Holdings) | 8.07B |
| CARsgen Therapeutics Holdings | 7.83B |
| Mirxes Holding Company | 7.08B |
| Laekna | 5.30B |
| Viva Biotech Holdings | 5.02B |
| Jacobio Pharmaceuticals Group | 4.91B |
| Shandong Boan Biotechnology | 4.89B |
| TYK Medicines | 4.78B |